67-5

77/110

) Motoya S, Tanaka H, Shibuya T, Osada T, Yamamoto T, Hongo H, Mizuno C, Saito D, Aoyama N, Kobayashi T, Ito H, Tanida S, Nojima M, Kokuma S, Hosoi E: Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflam-matory bowel disease in special situations: a multicentre cohort study. BMC Gastroen-terol. 2019 Nov 21; 19: 196.) Takahashi M, Ishikawa D, Sasaki T, Lu YJ, Kuwahara-Arai K, Kamei M, Shibuya T, Osada T, Hiramatsu K, Nagahara A: Faecal freezing preservation period influences colo-nization ability for faecal microbiota trans-plantation. J Appl Microbiol. 2019 Mar; 126: 973-984.K, Matsumoto K, Ueyama H, Sasaki H, Shimada Y, Matsumoto K, Osada T, Hojo M, Kato M, Nagahara A: Linked Color Imaging and the Kyoto Classification of Gastritis: Eval-uation of Visibility and Inter-Rater Reli-ability. Digestion, 2019; 12: 1-10.) Asaoka D, Takeda T, Sasaki H, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A: Evaluation of symptom-atic reflux esophagitis in proton pump inhib-itor users. Biomed Rep. 2019 May; 10: 277-282.) Komori H, Ueyama H, Nagahara A, Akazawa Y, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Yao T, Watanabe S: A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia. J Int Med Res. 2019; 47: 1441-1452. ) Atsukawa M, Tsubota A, Toyoda H, Taka-guchi K, Nakamuta M, Watanabe T, Michi-taka K, Ikegami T, Nozaki A, Uojima H, Fukunishi S, Genda T, Abe H, Hotta N, Tsuji K, Ogawa C, Tachi Y, Shima T, Shimada N, Kondo C, Akahane T, Aizawa Y, Tanaka Y, Kumada T, Iwakiri K: The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study. Aliment Pharmacol Ther. 2019 May; 49: 1230-1241.) Yoshida M, Takizawa K, Nonaka S, Shichijo S, Suzuki S, Sato C5, Komori H, Minagawa T, Oda I2, Uedo N, Hirasawa K, Matsumoto K, Sumiyoshi T, Mori K, Gotoda T, Ono H1; CONNECT-E Study Group: Conventional versus traction-assisted endoscopic submu-cosal dissection for large esophageal cancers: a multicenter, randomized controlled trial (with video). Gastrointest Endosc. 2020 Jan; 91: 55-65. e2. doi: 10.1016/j.gie.2019.08.014. Epub 2019 Aug 21.) Shibuya T, Nomura K, Okahara K, Haga K, Nomura O, Murakami T, Uchida S, Kodani T, Ishikawa D, Sakamoto N, Ogihara T, Osada T, Nagahara A: Budesonide Foam for Ulcer-ative Colitis Patients Experiencing Inade-quate Response to Biological Therapy. Med Sci Monit. 2019 Dec 22; 25: 9855-9863. 2 3 4 5 6 7 9＊ 10) Suzuki M, Kon K, Ikejima K, Arai K, Uchi-yama A, Aoyama T, Yamashina S, Ueno T, Watanabe S: The chemical chaperone 4-phen-ylbutyric acid prevents alcohol-induced liver injury in obese KK-Ay mice. Alcohol Clin Exp Res. 2019; 43: 617-627.＊ 11) Kitagawa R, Kon K, Uchiyama A, Arai K, Yamashina S, Kuwahara-Arai K, Kirikae T, Ueno T, Ikejima K: Rifaximin prevents etha-nol-induced liver injury in obese KK-Ay mice through modulation of small intestinal microbiota signature. Am J Physiol Gastroin-test Liver Physiol. 2019; 317: G707-G715. 12) Sato T, Yamashina S, Izumi K, Ueno T, Koike M, Ikejima K, Peters C, Watanabe S: Cathepsin L-deficiency enhances liver regeneration after partial hepatectomy. Life Sci. 2019; 221: 293- 300. 13) Moniaga CS, Iwamoto S, Kitamura T, Fujishiro M, Takahashi N, Katsunari K, Ogawa H, Tominaga M, Takamori K: Plasma Dynor-phin A Concentration Reflects the Degree of Pruritus in Chronic Liver Disease: A Prelimi-nary Report. Acta Derm Venereol. 2019 Apr 1; 99: 442-443. 14) Shimada Y, Matsumoto K, Ikeda Y, Amano N, Sato S, Murata A, Tomishima K, Tsuzura H, Sato S, Iijima K, Nagahara A, Genda T: Does PPI play a protective role in gastric mucosa in patients taking doacs ? and also in patients taking vka? Gastroenterology, 2019; 156: S503-S504. 15) Shimada Y, Matsumoto K, Ikeda Y, Amano 481